Both in Pharmaceuticals
Lifevantage Corporation Common Stock (Delaware) vs Corbus Pharmaceuticals Holdings
Over the past year LFVN returned −30.8% and CRBP returned −75.2%; their daily moves had a correlation of -0.02.
LFVN −30.8% CRBP −75.2%Growth of $1, one year, split-adjusted
| Metric | LFVN | CRBP |
|---|---|---|
| Price | $5.89 | $4.25 |
| Market cap | $74.2M | $82.2M |
| Today | −0.67% | +2.41% |
| 1 month | −6.8% | −35.9% |
| 6 months | +16.6% | −56.7% |
| Year to date | −4.4% | −47.8% |
| 1 year | −30.9% | −75.0% |
| Revenue growth (YoY) | −23.1% | — |
| Gross margin | 78.0% | — |
| Net margin | 3.0% | — |
| P/E (TTM) | 14.6× | — |
| Price / sales | 0.4× | — |
| Net cash | $14.9M | $117.9M |
| Dividend yield | 3.40% | — |
| Volatility (60d) | 26.0% | 72.5% |
| Short % of float | 9.5% | 16.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).